Background. Acute non-traumatic focal subarachnoid haemorrhage (fSAH) is a rare transient ischaemic attack (TIA)-mimic. MRI is considered to be indispensable by some authors in order to avoid ...
Below is a review of novel drug and biological products approved by the Food and Drug Administration (FDA) in 2024. The list includes several groundbreaking therapies that are expected to change the ...
Intracerebral hemorrhage is a medical emergency (Broderick et al., 1999). Initial diagnosis is achieved by using an emergent brain computed tomography (CT) scan upon presentation. A CT scan can ...
However, there was no benefit on outcome, with an increased number of systemic complications, such as pulmonary oedema and metabolic derangements in the treatment ... and Therapeutic Management of ...
Autolus Therapeutics plc (Nasdaq: AUTL), a commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, announces an oral ...
Correction for ‘Protocol for a multisite randomised controlled trial assessing the effect of the Telehealth for early developmental Intervention in babies born very preterm (TEDI-Prem) programme on ...